Filing Details
- Accession Number:
- 0001213900-22-032625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-14 08:01:45
- Reporting Period:
- 2022-06-13
- Accepted Time:
- 2022-06-14 08:01:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 811641 | Immucell Corp | ICCC | In Vitro & In Vivo Diagnostic Substances (2835) | 010382980 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1529247 | David Cunningham | C/O Immucell Corporation 56 Evergreen Drive Portland ME 04103 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $0.10 Per Value Per Share | Acquisiton | 2022-06-13 | 1,000 | $8.00 | 16,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
